Why the study?
Cardiovascular disease is the leading cause of death among women worldwide, yet women have historically been underrepresented in cardiovascular clinical trials.
Population
Completed cardiovascular trials registered in ClinicalTrials.gov between 2010 and 2017
Design
Systematic assessment of clinical trials
Authors
Loading...
Women remain underrepresented in many CV trials, limiting applicability to female patients; confirms need for targeted recruitment and sex-specific analyses going forward.
Women remain underrepresented in cardiovascular clinical trials overall, though participation has improved in specific areas like stroke and heart failure.
Jin et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: